The U.S. Food and Drug Administration (FDA) said Wednesday a diagnostic test developed by the Defense Department to detect Ebola has been authorized for use in helping to contain the worst outbreak of the deadly virus. The in-vitro diagnostic was authorized for use in laboratories designated by the Defense Department to help respond to the ongoing Ebola outbreak in West Africa, the FDA said. The test is intended for use by U.S. defense personnel with symptoms of Ebola but may be used to test aid workers and responders. More than 900 people have died in the West Africa Ebola outbreak, which has overwhelmed the healthcare systems in some countries and prompted the deployment of soldiers to quarantine the worst-hit areas in the remote border region of Guinea, Liberia, and Sierra Leone.
